Comparison Chart BioInvent International AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 08:59:51 17/05/2024 pm IST			5-day change	1st Jan Change
29.95 ^SEK	+1.53%		+19.32%	+57.96%

14/05	Bioinvent to Present Additional Promising Phase 1/2A Data At EHA 2024 for BI-1206 with rituximab in NHL	CI
03/05	Bioinvent International AB Resolves to Elect Laura Lassouw-Polman as New Board Member	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	BIOINVENT INTERNATIONAL AB	Bio Therapeutic Drugs	+1.53%	+19.32%	+57.96%	+15.19%	-4.47%	184M